EMA reviewing possible link between Johnson & Johnson Covid-19 vaccine and blood clots

The European Medicines Agency announced Friday that it is reviewing a possible connection between the Johnson & Johnson Covid-19 vaccine and blood clots, Reuters reports.
"Four serious cases of rare blood clots with low platelets, one of which was fatal, have been reported after inoculation with J&J’s vaccine from its Janssen unit, the European Medicines Agency’s (EMA) said," Reuters wrote.